Innovation

V2 Vasopressin Antagonists (Technology#: 091405-01)

Lehigh University Office of Technology Transfer
posted on 07/10/2009

Novel 2-(azetidin-2-on-1-yl)alkanedioic acid derivatives and 2-(azetidin-2-on-1-yl)alkoxyalkanoic acid derivatives are described for use in the treatment of disease states responsive to antagonism of the vasopressin V.sub.1a receptor ##STR00001##

 
Applications
*Treatment of diseased mammals
 
Status of Intellectual Property
This technology is protected under US Patent 7,268,125
 
]]>


Innovation Details
 

File Number: 091405-01 


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Yatin Karpe at Lehigh University Office of Technology Transfer for more information.

Request more info via email request more info
People

Case Manager:

Yatin Karpe Yatin Karpe

Innovations (63)

Download Technology Brief (PDF)


[?]
Followed By

Follow this innovation



No one is following this innovation.

Organization
4279

Lehigh University Office of Technology Transfer


Communities
Profile
Related Tags

Find more innovations

February 11, 2009

7,783 members 17,070 innovations 152 organizations

Browse

William Garner, M.D., MPH - CEO of Urigen, N.A., Inc.

"The iBridge Network provides an important additional pathway for entrepreneurs to access university innovations that may otherwise have been lost. The transparency of this pathway between entrepreneurs..."  read more...